CALCIUM BIS[2S)-3-[3-(2S)-3-(4-CHLORO-2-CYANOPHENOXY)-2- FLUOROPROPOXY¨PHENYL]-2-ISOPROPOXYPROPIONATE] AND INTERMEDIATE THEREOF
The present invention relates to calcium bis[(2 S )-3-[3-[(2 S )-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl]-2-isopropoxypropionate] represented by formula (I), a hydrate thereof, a crystal of the compound of formula (I), and a crystal of the hydrate of the compound of formula (I) which are...
Saved in:
Main Authors | , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
22.09.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to calcium bis[(2 S )-3-[3-[(2 S )-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl]-2-isopropoxypropionate] represented by formula (I), a hydrate thereof, a crystal of the compound of formula (I), and a crystal of the hydrate of the compound of formula (I) which are useful as pharmaceuticals, and to processes for producing the same, and intermediates therefore, and processes for production thereof. [Problem] There is need for (2 S )-3-[3-[(2 S )-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl]-2-isopropoxypropionic acid, in the form of a drug substance, purified so as to minimize a residual solvent content and having a uniformized specification and a highly favorable workability, and a process for producing the same. [Solution] Crystalline calcium bis[(2 S )-3-[3-[(2 S )-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl]-2-isopropoxypropionate], a calcium salt of (2 S )-3-[3-[(2 S )-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl]-2-isopropoxypropionic acid, solves the above problem. |
---|---|
AbstractList | The present invention relates to calcium bis[(2 S )-3-[3-[(2 S )-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl]-2-isopropoxypropionate] represented by formula (I), a hydrate thereof, a crystal of the compound of formula (I), and a crystal of the hydrate of the compound of formula (I) which are useful as pharmaceuticals, and to processes for producing the same, and intermediates therefore, and processes for production thereof. [Problem] There is need for (2 S )-3-[3-[(2 S )-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl]-2-isopropoxypropionic acid, in the form of a drug substance, purified so as to minimize a residual solvent content and having a uniformized specification and a highly favorable workability, and a process for producing the same. [Solution] Crystalline calcium bis[(2 S )-3-[3-[(2 S )-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl]-2-isopropoxypropionate], a calcium salt of (2 S )-3-[3-[(2 S )-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl]-2-isopropoxypropionic acid, solves the above problem. |
Author | HAYASHI, KENJI SASHO, MANABU MIYAZAWA, MAMORU GOTODA, MASAHARU MATSUURA, FUMIYOSHI INOUE, SUSUMU NISHIURA, KATSUTOSHI OZEKI, NOAKI HISATAKE, YOSHIHIKO SHINODA, MASANOBU TAKIGAWA, TEIJI MURATA, KAORU NEGI, SHIGETO MATSUYAMA, KEISUKE |
Author_xml | – fullname: HISATAKE, YOSHIHIKO – fullname: SASHO, MANABU – fullname: INOUE, SUSUMU – fullname: MATSUYAMA, KEISUKE – fullname: HAYASHI, KENJI – fullname: GOTODA, MASAHARU – fullname: TAKIGAWA, TEIJI – fullname: NEGI, SHIGETO – fullname: MURATA, KAORU – fullname: MIYAZAWA, MAMORU – fullname: MATSUURA, FUMIYOSHI – fullname: NISHIURA, KATSUTOSHI – fullname: SHINODA, MASANOBU – fullname: OZEKI, NOAKI |
BookMark | eNrjYmDJy89L5WRocHb0cfYM9VVw8gyONgrW1DXWjTbW1YCwNEx0nT18_IP8dY10nSMd_fwDPFz9_CMiNYF8BTefUKBMABABRQ6tAElF-sQCZTyDYaIgytPfzzHENVbB0c9FwdMvxDXI19XFEyiiEOLhGuTq78bDwJqWmFOcyguluRkU3FxDnD10Uwvy41OLCxKTU_NSS-JdAwwtzI0NTQwdTYyJUAIAnYs-Sw |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | BIS[(2S)-3-[3-](2S)-3-(4-CHLORO-2-CYANOPHENOXY)-2-FLUOROPROPOXY]PHENYL]-2-ISOPROPOXYPROPIONATE]DE CALCIUM ET INTERMEDIAIRE DE CELUI-CI CALCIUM-BIS[2S)-3-[3-(2S)-3-(4-CHLOR-2-CYANOPHENOXY)-2- FLUORPROPOXYPHENYL]-2-ISOPROPOXYPROPIONAT] UND ZWISCHENPRODUKTE DAVON |
ExternalDocumentID | EP1873141A4 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP1873141A43 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:55:59 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP1873141A43 |
Notes | Application Number: EP20060745431 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100922&DB=EPODOC&CC=EP&NR=1873141A4 |
ParticipantIDs | epo_espacenet_EP1873141A4 |
PublicationCentury | 2000 |
PublicationDate | 20100922 |
PublicationDateYYYYMMDD | 2010-09-22 |
PublicationDate_xml | – month: 09 year: 2010 text: 20100922 day: 22 |
PublicationDecade | 2010 |
PublicationYear | 2010 |
RelatedCompanies | EISAI R&D MANAGEMENT CO., LTD |
RelatedCompanies_xml | – name: EISAI R&D MANAGEMENT CO., LTD |
Score | 2.7886803 |
Snippet | The present invention relates to calcium bis[(2 S )-3-[3-[(2 S )-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl]-2-isopropoxypropionate] represented by... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | CALCIUM BIS[2S)-3-[3-(2S)-3-(4-CHLORO-2-CYANOPHENOXY)-2- FLUOROPROPOXY¨PHENYL]-2-ISOPROPOXYPROPIONATE] AND INTERMEDIATE THEREOF |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100922&DB=EPODOC&locale=&CC=EP&NR=1873141A4 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFA5zivqmU3He6IOU7SG4Jlm3PAzp0pROurbsIhsyRm-DvXTDVXz15_g7_GUm3UVfFAI5OQcC58CX-_kCwD0JCY2ipAlJQGNICE1g0KgnMMS1SEN6VNOaMsG56-r2kDyN6qMCmG9zYXKe0PecHFEgKhJ4z_LxevlziGXmbytXD-FcqBaP1qBlqpvdsSYphJBqtlvc90yPqYwJSXV7AuQNrBHNIHtgX6yiG_L1F39uy6SU5e8ZxToBB77oLM1OQSFJS-CIbT9eK4HD7ua-W4gb6K3OwAczHNYZdpV2p_-C-lWI4QuGlbVUIZDZjtfzIIJsbLieb3PXG42roq1YzlBYfFGE5utTmsbORFg6_a1WVpIUd8AniuGaSk6UK5kfhUYZ2LzHPescKBYfMBsKV6a7sE25v3MaX4BiukiTS6DoNZxQPItpiGckiAhFWoAiEmM9pkGCgjIo_9nN1T-2a3C8vlinEKEbUMxe35JbMV9n4V0e6W_lN5F1 |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9zivNNp-L87IOU7SG4Jlm3Pgzp0pRWu7ZsnWyMMfo12Es3XMVX_xz_Dv8y0-5DXxQCudxB4A4ul-RyvwBwTwKihGHcgsRXIkiIEkO_2YhhgOuhhOSwLrWyAueuLRsD8jRsDAtgvq2FyXFC33NwRO5RIff3NF-vlz-XWFr-tnL1EMw5a_Goe21N3JyOpQxCCIlap81cR3OoSCmnRLvHnbyJJSKpZA_s8x12K4PZZy-drChl-Tui6MfgwOWTJekJKMRJGZTo9uO1MjjsbvLdnNy43uoUfFDVouagK3TM_hj1axDDMYbVNVUlkBqW03MggnSk2o5rMNsZjmp8LOjWgEtc3jjn6zMTjawJl5j9LTfrMlBcj00E1daEHCg3Q37kHMEzWI85-hkQdOZRA3JVpjuzTZm7Uxqfg2KySOILIMh1HCt4FikBnhE_JAqSfBSSCMuR4sfIr4DKn9Nc_iO7AyXD61pTy7Sfr8DROsmuQISuQTF9fYtveOxOg9vc6t_g7pRl |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CALCIUM+BIS%5B2S%29-3-%5B3-%282S%29-3-%284-CHLORO-2-CYANOPHENOXY%29-2-+FLUOROPROPOXY%C2%A8PHENYL%5D-2-ISOPROPOXYPROPIONATE%5D+AND+INTERMEDIATE+THEREOF&rft.inventor=HISATAKE%2C+YOSHIHIKO&rft.inventor=SASHO%2C+MANABU&rft.inventor=INOUE%2C+SUSUMU&rft.inventor=MATSUYAMA%2C+KEISUKE&rft.inventor=HAYASHI%2C+KENJI&rft.inventor=GOTODA%2C+MASAHARU&rft.inventor=TAKIGAWA%2C+TEIJI&rft.inventor=NEGI%2C+SHIGETO&rft.inventor=MURATA%2C+KAORU&rft.inventor=MIYAZAWA%2C+MAMORU&rft.inventor=MATSUURA%2C+FUMIYOSHI&rft.inventor=NISHIURA%2C+KATSUTOSHI&rft.inventor=SHINODA%2C+MASANOBU&rft.inventor=OZEKI%2C+NOAKI&rft.date=2010-09-22&rft.externalDBID=A4&rft.externalDocID=EP1873141A4 |